Focused on product safety
Actavis is focused on product safety and conducts comprehensive safety monitoring and evaluations throughout all stages of our product lifecycle.
Patient safety is Actavis' primary concern and we encourage healthcare professionals and patients to report any adverse event which may occur in relation to an Actavis product. An adverse event includes reports of any side effect, product misuse, abuse or overdose, including inappropriate use by children or women who are pregnant or breast-feeding. It also includes reports of a product that was used for something other than the intended purpose or was ineffective, or was given with another medicine. Complaints relating to the product can also be reported.
Adverse events should be reported either directly to The Medicines and Healthcare Products Regulatory Agency (MHRA) through its Yellow Card reporting system or you can contact Actavis Medical Information directly on 01271 385257
If you have any medical queries or any feedback you would like to give us, please use the Medical Information email address below, and we will be pleased to get back to you.Medical Information Department
Actavis UK Ltd
EX32 8NS UK
Telephone: +44 (0) 1271 385257
Fax: +44 (0) 1271 346106